Rare Disease Day 2019: What makes a cancer rare and how can research help? 28 Feb 2019 On 28 February organisations around the world will be working to raise awareness of rare diseases for Rare Disease Day. Tilly Haynes looked into what qualifies as a rare cancer, and how researchers at The Institute of Cancer Research, London, are working on some of them. Find out more Show/Hide
“The future’s bright” – Professor Udai Banerji reflects on the evolution of anticancer drugs 21 Jan 2019 Marking his promotion to Professor after 18 years at The Institute of Cancer Research, Professor Udai Banerji gave his inaugural lecture to packed lecture theatres across our two sites. Conor McKeever, our Science Communications Officer, was there to hear him talk about his work on the development of new anticancer drugs, and where he sees the field going next. Find out more Show/Hide
NCRI 2016: Could exciting new treatments to block cancer evolution halt drug resistance? 15 Nov 2016 Cancer can evolve stubborn resistance to even our best therapies, threatening our ability to treat tumours effectively. But new research promises to solve this pressing problem and deliver better survival rates for patients. Find out more Show/Hide